This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Fox, J. Puzzling industry response to ProdiGene fiasco. Nat Biotechnol 21, 3–4 (2003). https://doi.org/10.1038/nbt0103-3b
Issue Date:
DOI: https://doi.org/10.1038/nbt0103-3b
This article is cited by
-
Recombinant pharmaceutical protein production in plants: unraveling the therapeutic potential of molecular pharming
Acta Physiologiae Plantarum (2017)
-
Knowledge-technology-based discovery of unauthorized genetically modified organisms
Analytical and Bioanalytical Chemistry (2010)
-
GMO testing—trade, labeling or safety first?
Nature Biotechnology (2008)
-
Elastin-like polypeptide fusions enhance the accumulation of recombinant proteins in tobacco leaves
Transgenic Research (2007)